|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Assets | |
| Current Assets | |
| Cash | |
| Loan Receivable (L/R) | |
| Interest Receivable | |
| Allowance for Bad Debt | |
| Total Assets | |
| Liabilities and Stockholders’ Deficit | |
| Current Liabilities | |
| Accounts Payable and accrued Liabilities | |
| Notes Payable (N/P) | |
| Interest Payable & Other Payables | |
| Due to Related Party | |
| Total for Current Liabilities | |
| Total for Liabilities | |
| Stockholder’ Deficit: | |
| Common Stock $0.001 par value,1,000,000,000 shares authorized:182,289,904 and 171,731,956 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | |
| Additional paid in capital | |
| Accumulated Deficit | |
| Total Stockholders’ Deficit | |
| Total for Liabilities and Stockholders’ Deficit | |
| Revenues | |
| Cost of Revenues | |
| Gross Profit | |
| General and Administrative | |
| Professional Fees | |
| Payroll Expense | |
| Other Expenses | |
| Total Operating Expenses | |
| Loss from Operations | |
| Other Income | |
| Interest Income | |
| Interest Expense | |
| Total Other Income (Expense) | |
| Loss before income taxes | |
| Net Loss |
Loading...
